AdaptHealth Corp vs iShares MSCI Indonesia ETF — how do they compare? AdaptHealth Corp trades at $5.78 (market cap $753.09M), while iShares MSCI Indonesia ETF trades at $12.64. The key difference: iShares MSCI Indonesia ETF is trading nearer its 52-week high, AdaptHealth Corp nearer its low. Which is the better fit depends on your goals.
| AHCO | EIDO | |
|---|---|---|
Market Cap | $753.09M | — |
Sector | Health | — |
52-Week High | $13.38 | $19.22 |
52-Week Low | $5.22 | $10.80 |
Enterprise Value | $2.77B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
EIDO trades at $12.64, down 0.86% on the day, with a bearish technical signal from moving averages and mixed oscillators. The stock faces headwinds from foreign capital outflows in Asian equities and Indonesia's economic exposure. A dividend of $0.23 is scheduled for payment in June 2026, offering income potential amid weak price action.
The outlook remains cautious due to technical downtrends and macroeconomic pressures on Indonesian assets. Investment appeal hinges on valuation discounts and potential policy support, but risks include currency volatility and limited earnings growth. Investors require patience for a turnaround.
Trailing returns across standard periods
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Indonesia. The fund is non-diversified.
Read more on EIDO →